← Open Payments lookup

REBECCA MIZRAHI: Open Payments

NPI 1104499409 · OCEANPORT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,592 in 100 payments from 16 companies in 2025. Trend: 2023 $1,513 · 2024 $884 · 2025 $1,592

Food & beverage: $1,592
CompanyPaymentsAmount
Axsome Therapeutics, Inc.11$269
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$253
Alkermes, Inc.14$235
ABBVIE INC.18$175
Vanda Pharmaceuticals Inc.8$147
Lundbeck LLC11$137
Takeda Pharmaceuticals U.S.A., Inc.5$88
Bausch Health US, LLC4$70
Otsuka America Pharmaceutical, Inc.4$64
Supernus Pharmaceuticals, Inc.2$41

Products named: Auvelity, CAPLYTA, REXULTI, ARISTADA, VRAYLAR, FANAPT, TRINTELLIX, APLENZIN.

Industry payments across NJ — which companies pay providers there.